ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-9D10148
Home | Market Reports | Health| Pharmacy
Global Peptide Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Peptide Vaccine Market Research Report 2025

Code: QYRE-Auto-9D10148
Report
July 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Anergis
Celgene Corporation
Immatics Biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
OncoTherapy Science
Sumitomo Dainippon Pharma
TapImmune
Targovax
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Spotlight Innovation
Peptech
Pharmasyntez

Peptide Vaccine Market Size

The global market for Peptide Vaccine was valued at US$ 3982 million in the year 2024 and is projected to reach a revised size of US$ 5325 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Peptide Vaccine Market

Peptide Vaccine Market

Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peptide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Vaccine.
The Peptide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Peptide Vaccine Market Report

Report Metric Details
Report Name Peptide Vaccine Market
Accounted market size in year US$ 3982 million
Forecasted market size in 2031 US$ 5325 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies, Benovus Bio, Celgene Corporation, Immatics biotechnologies, Merck, ImmunoCellular Therapeutics, ISA Pharmaceuticals, Lytix Biopharma, Spotlight Innovation, OncoTherapy Science, Peptech, Pharmasyntez, Sumitomo Dainippon Pharma, TapImmune, Targovax
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Peptide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Peptide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Peptide Vaccine Market growing?

Ans: The Peptide Vaccine Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Peptide Vaccine Market size in 2031?

Ans: The Peptide Vaccine Market size in 2031 will be US$ 5325 million.

Who are the main players in the Peptide Vaccine Market report?

Ans: The main players in the Peptide Vaccine Market are Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies, Benovus Bio, Celgene Corporation, Immatics biotechnologies, Merck, ImmunoCellular Therapeutics, ISA Pharmaceuticals, Lytix Biopharma, Spotlight Innovation, OncoTherapy Science, Peptech, Pharmasyntez, Sumitomo Dainippon Pharma, TapImmune, Targovax

What are the Application segmentation covered in the Peptide Vaccine Market report?

Ans: The Applications covered in the Peptide Vaccine Market report are Prostate Cancer, Breast Cancer, Gastric Cancer, Lung Cancer, Pancreatic Cancer, Others

What are the Type segmentation covered in the Peptide Vaccine Market report?

Ans: The Types covered in the Peptide Vaccine Market report are Solution Phase Synthesis (SPS), Solid Phase Peptide Synthesis (SPPS)

Recommended Reports

Human Vaccine Markets

Multivalent & Combination Vaccines

Advanced Vaccine Platforms

1 Peptide Vaccine Market Overview
1.1 Product Definition
1.2 Peptide Vaccine by Type
1.2.1 Global Peptide Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Solution Phase Synthesis (SPS)
1.2.3 Solid Phase Peptide Synthesis (SPPS)
1.3 Peptide Vaccine by Application
1.3.1 Global Peptide Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Gastric Cancer
1.3.5 Lung Cancer
1.3.6 Pancreatic Cancer
1.3.7 Others
1.4 Global Peptide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Peptide Vaccine Revenue 2020-2031
1.4.2 Global Peptide Vaccine Sales 2020-2031
1.4.3 Global Peptide Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Peptide Vaccine Market Competition by Manufacturers
2.1 Global Peptide Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Peptide Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Peptide Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Peptide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peptide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peptide Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Peptide Vaccine, Date of Enter into This Industry
2.8 Global Peptide Vaccine Market Competitive Situation and Trends
2.8.1 Global Peptide Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Peptide Vaccine Players Market Share by Revenue
2.8.3 Global Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Peptide Vaccine Market Scenario by Region
3.1 Global Peptide Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Peptide Vaccine Sales by Region: 2020-2031
3.2.1 Global Peptide Vaccine Sales by Region: 2020-2025
3.2.2 Global Peptide Vaccine Sales by Region: 2026-2031
3.3 Global Peptide Vaccine Revenue by Region: 2020-2031
3.3.1 Global Peptide Vaccine Revenue by Region: 2020-2025
3.3.2 Global Peptide Vaccine Revenue by Region: 2026-2031
3.4 North America Peptide Vaccine Market Facts & Figures by Country
3.4.1 North America Peptide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Peptide Vaccine Sales by Country (2020-2031)
3.4.3 North America Peptide Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Peptide Vaccine Market Facts & Figures by Country
3.5.1 Europe Peptide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Peptide Vaccine Sales by Country (2020-2031)
3.5.3 Europe Peptide Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peptide Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Peptide Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Peptide Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Peptide Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Peptide Vaccine Market Facts & Figures by Country
3.7.1 Latin America Peptide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Peptide Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Peptide Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peptide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Peptide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Peptide Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Peptide Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Peptide Vaccine Sales by Type (2020-2031)
4.1.1 Global Peptide Vaccine Sales by Type (2020-2025)
4.1.2 Global Peptide Vaccine Sales by Type (2026-2031)
4.1.3 Global Peptide Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Peptide Vaccine Revenue by Type (2020-2031)
4.2.1 Global Peptide Vaccine Revenue by Type (2020-2025)
4.2.2 Global Peptide Vaccine Revenue by Type (2026-2031)
4.2.3 Global Peptide Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Peptide Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Peptide Vaccine Sales by Application (2020-2031)
5.1.1 Global Peptide Vaccine Sales by Application (2020-2025)
5.1.2 Global Peptide Vaccine Sales by Application (2026-2031)
5.1.3 Global Peptide Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Peptide Vaccine Revenue by Application (2020-2031)
5.2.1 Global Peptide Vaccine Revenue by Application (2020-2025)
5.2.2 Global Peptide Vaccine Revenue by Application (2026-2031)
5.2.3 Global Peptide Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Peptide Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Anergis
6.1.1 Anergis Company Information
6.1.2 Anergis Description and Business Overview
6.1.3 Anergis Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Anergis Peptide Vaccine Product Portfolio
6.1.5 Anergis Recent Developments/Updates
6.2 Antigen Express
6.2.1 Antigen Express Company Information
6.2.2 Antigen Express Description and Business Overview
6.2.3 Antigen Express Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Antigen Express Peptide Vaccine Product Portfolio
6.2.5 Antigen Express Recent Developments/Updates
6.3 Apitope Technology
6.3.1 Apitope Technology Company Information
6.3.2 Apitope Technology Description and Business Overview
6.3.3 Apitope Technology Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Apitope Technology Peptide Vaccine Product Portfolio
6.3.5 Apitope Technology Recent Developments/Updates
6.4 Artificial Cell Technologies
6.4.1 Artificial Cell Technologies Company Information
6.4.2 Artificial Cell Technologies Description and Business Overview
6.4.3 Artificial Cell Technologies Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Artificial Cell Technologies Peptide Vaccine Product Portfolio
6.4.5 Artificial Cell Technologies Recent Developments/Updates
6.5 Benovus Bio
6.5.1 Benovus Bio Company Information
6.5.2 Benovus Bio Description and Business Overview
6.5.3 Benovus Bio Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Benovus Bio Peptide Vaccine Product Portfolio
6.5.5 Benovus Bio Recent Developments/Updates
6.6 Celgene Corporation
6.6.1 Celgene Corporation Company Information
6.6.2 Celgene Corporation Description and Business Overview
6.6.3 Celgene Corporation Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Celgene Corporation Peptide Vaccine Product Portfolio
6.6.5 Celgene Corporation Recent Developments/Updates
6.7 Immatics biotechnologies
6.7.1 Immatics biotechnologies Company Information
6.7.2 Immatics biotechnologies Description and Business Overview
6.7.3 Immatics biotechnologies Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Immatics biotechnologies Peptide Vaccine Product Portfolio
6.7.5 Immatics biotechnologies Recent Developments/Updates
6.8 Merck
6.8.1 Merck Company Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck Peptide Vaccine Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 ImmunoCellular Therapeutics
6.9.1 ImmunoCellular Therapeutics Company Information
6.9.2 ImmunoCellular Therapeutics Description and Business Overview
6.9.3 ImmunoCellular Therapeutics Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 ImmunoCellular Therapeutics Peptide Vaccine Product Portfolio
6.9.5 ImmunoCellular Therapeutics Recent Developments/Updates
6.10 ISA Pharmaceuticals
6.10.1 ISA Pharmaceuticals Company Information
6.10.2 ISA Pharmaceuticals Description and Business Overview
6.10.3 ISA Pharmaceuticals Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ISA Pharmaceuticals Peptide Vaccine Product Portfolio
6.10.5 ISA Pharmaceuticals Recent Developments/Updates
6.11 Lytix Biopharma
6.11.1 Lytix Biopharma Company Information
6.11.2 Lytix Biopharma Description and Business Overview
6.11.3 Lytix Biopharma Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Lytix Biopharma Peptide Vaccine Product Portfolio
6.11.5 Lytix Biopharma Recent Developments/Updates
6.12 Spotlight Innovation
6.12.1 Spotlight Innovation Company Information
6.12.2 Spotlight Innovation Description and Business Overview
6.12.3 Spotlight Innovation Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Spotlight Innovation Peptide Vaccine Product Portfolio
6.12.5 Spotlight Innovation Recent Developments/Updates
6.13 OncoTherapy Science
6.13.1 OncoTherapy Science Company Information
6.13.2 OncoTherapy Science Description and Business Overview
6.13.3 OncoTherapy Science Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 OncoTherapy Science Peptide Vaccine Product Portfolio
6.13.5 OncoTherapy Science Recent Developments/Updates
6.14 Peptech
6.14.1 Peptech Company Information
6.14.2 Peptech Description and Business Overview
6.14.3 Peptech Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Peptech Peptide Vaccine Product Portfolio
6.14.5 Peptech Recent Developments/Updates
6.15 Pharmasyntez
6.15.1 Pharmasyntez Company Information
6.15.2 Pharmasyntez Description and Business Overview
6.15.3 Pharmasyntez Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Pharmasyntez Peptide Vaccine Product Portfolio
6.15.5 Pharmasyntez Recent Developments/Updates
6.16 Sumitomo Dainippon Pharma
6.16.1 Sumitomo Dainippon Pharma Company Information
6.16.2 Sumitomo Dainippon Pharma Description and Business Overview
6.16.3 Sumitomo Dainippon Pharma Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Sumitomo Dainippon Pharma Peptide Vaccine Product Portfolio
6.16.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.17 TapImmune
6.17.1 TapImmune Company Information
6.17.2 TapImmune Description and Business Overview
6.17.3 TapImmune Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 TapImmune Peptide Vaccine Product Portfolio
6.17.5 TapImmune Recent Developments/Updates
6.18 Targovax
6.18.1 Targovax Company Information
6.18.2 Targovax Description and Business Overview
6.18.3 Targovax Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Targovax Peptide Vaccine Product Portfolio
6.18.5 Targovax Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peptide Vaccine Industry Chain Analysis
7.2 Peptide Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peptide Vaccine Production Mode & Process Analysis
7.4 Peptide Vaccine Sales and Marketing
7.4.1 Peptide Vaccine Sales Channels
7.4.2 Peptide Vaccine Distributors
7.5 Peptide Vaccine Customer Analysis
8 Peptide Vaccine Market Dynamics
8.1 Peptide Vaccine Industry Trends
8.2 Peptide Vaccine Market Drivers
8.3 Peptide Vaccine Market Challenges
8.4 Peptide Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Anergis
Celgene Corporation
Immatics Biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
OncoTherapy Science
Sumitomo Dainippon Pharma
TapImmune
Targovax
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Spotlight Innovation
Peptech
Pharmasyntez
List of Tables
 Table 1. Global Peptide Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Peptide Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Peptide Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Peptide Vaccine Sales (K Dose) of Key Manufacturers (2020-2025)
 Table 5. Global Peptide Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Peptide Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Peptide Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Peptide Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Peptide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Peptide Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Peptide Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Peptide Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Peptide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Peptide Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Peptide Vaccine Sales by Region (2020-2025) & (K Dose)
 Table 18. Global Peptide Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Peptide Vaccine Sales by Region (2026-2031) & (K Dose)
 Table 20. Global Peptide Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Peptide Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Peptide Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Peptide Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Peptide Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Peptide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Peptide Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 27. North America Peptide Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 28. North America Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Peptide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Peptide Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 32. Europe Peptide Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 33. Europe Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Peptide Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Peptide Vaccine Sales by Region (2020-2025) & (K Dose)
 Table 37. Asia Pacific Peptide Vaccine Sales by Region (2026-2031) & (K Dose)
 Table 38. Asia Pacific Peptide Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Peptide Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Peptide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Peptide Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 42. Latin America Peptide Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 43. Latin America Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Peptide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Peptide Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 47. Middle East and Africa Peptide Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 48. Middle East and Africa Peptide Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Peptide Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Peptide Vaccine Sales (K Dose) by Type (2020-2025)
 Table 51. Global Peptide Vaccine Sales (K Dose) by Type (2026-2031)
 Table 52. Global Peptide Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Peptide Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Peptide Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Peptide Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Peptide Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Peptide Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Peptide Vaccine Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Peptide Vaccine Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Peptide Vaccine Sales (K Dose) by Application (2020-2025)
 Table 61. Global Peptide Vaccine Sales (K Dose) by Application (2026-2031)
 Table 62. Global Peptide Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Peptide Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Peptide Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Peptide Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Peptide Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Peptide Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Peptide Vaccine Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Peptide Vaccine Price (US$/Dose) by Application (2026-2031)
 Table 70. Anergis Company Information
 Table 71. Anergis Description and Business Overview
 Table 72. Anergis Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. Anergis Peptide Vaccine Product
 Table 74. Anergis Recent Developments/Updates
 Table 75. Antigen Express Company Information
 Table 76. Antigen Express Description and Business Overview
 Table 77. Antigen Express Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. Antigen Express Peptide Vaccine Product
 Table 79. Antigen Express Recent Developments/Updates
 Table 80. Apitope Technology Company Information
 Table 81. Apitope Technology Description and Business Overview
 Table 82. Apitope Technology Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Apitope Technology Peptide Vaccine Product
 Table 84. Apitope Technology Recent Developments/Updates
 Table 85. Artificial Cell Technologies Company Information
 Table 86. Artificial Cell Technologies Description and Business Overview
 Table 87. Artificial Cell Technologies Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Artificial Cell Technologies Peptide Vaccine Product
 Table 89. Artificial Cell Technologies Recent Developments/Updates
 Table 90. Benovus Bio Company Information
 Table 91. Benovus Bio Description and Business Overview
 Table 92. Benovus Bio Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. Benovus Bio Peptide Vaccine Product
 Table 94. Benovus Bio Recent Developments/Updates
 Table 95. Celgene Corporation Company Information
 Table 96. Celgene Corporation Description and Business Overview
 Table 97. Celgene Corporation Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. Celgene Corporation Peptide Vaccine Product
 Table 99. Celgene Corporation Recent Developments/Updates
 Table 100. Immatics biotechnologies Company Information
 Table 101. Immatics biotechnologies Description and Business Overview
 Table 102. Immatics biotechnologies Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. Immatics biotechnologies Peptide Vaccine Product
 Table 104. Immatics biotechnologies Recent Developments/Updates
 Table 105. Merck Company Information
 Table 106. Merck Description and Business Overview
 Table 107. Merck Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 108. Merck Peptide Vaccine Product
 Table 109. Merck Recent Developments/Updates
 Table 110. ImmunoCellular Therapeutics Company Information
 Table 111. ImmunoCellular Therapeutics Description and Business Overview
 Table 112. ImmunoCellular Therapeutics Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 113. ImmunoCellular Therapeutics Peptide Vaccine Product
 Table 114. ImmunoCellular Therapeutics Recent Developments/Updates
 Table 115. ISA Pharmaceuticals Company Information
 Table 116. ISA Pharmaceuticals Description and Business Overview
 Table 117. ISA Pharmaceuticals Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 118. ISA Pharmaceuticals Peptide Vaccine Product
 Table 119. ISA Pharmaceuticals Recent Developments/Updates
 Table 120. Lytix Biopharma Company Information
 Table 121. Lytix Biopharma Description and Business Overview
 Table 122. Lytix Biopharma Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 123. Lytix Biopharma Peptide Vaccine Product
 Table 124. Lytix Biopharma Recent Developments/Updates
 Table 125. Spotlight Innovation Company Information
 Table 126. Spotlight Innovation Description and Business Overview
 Table 127. Spotlight Innovation Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 128. Spotlight Innovation Peptide Vaccine Product
 Table 129. Spotlight Innovation Recent Developments/Updates
 Table 130. OncoTherapy Science Company Information
 Table 131. OncoTherapy Science Description and Business Overview
 Table 132. OncoTherapy Science Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 133. OncoTherapy Science Peptide Vaccine Product
 Table 134. OncoTherapy Science Recent Developments/Updates
 Table 135. Peptech Company Information
 Table 136. Peptech Description and Business Overview
 Table 137. Peptech Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 138. Peptech Peptide Vaccine Product
 Table 139. Peptech Recent Developments/Updates
 Table 140. Pharmasyntez Company Information
 Table 141. Pharmasyntez Description and Business Overview
 Table 142. Pharmasyntez Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 143. Pharmasyntez Peptide Vaccine Product
 Table 144. Pharmasyntez Recent Developments/Updates
 Table 145. Sumitomo Dainippon Pharma Company Information
 Table 146. Sumitomo Dainippon Pharma Description and Business Overview
 Table 147. Sumitomo Dainippon Pharma Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 148. Sumitomo Dainippon Pharma Peptide Vaccine Product
 Table 149. Sumitomo Dainippon Pharma Recent Developments/Updates
 Table 150. TapImmune Company Information
 Table 151. TapImmune Description and Business Overview
 Table 152. TapImmune Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 153. TapImmune Peptide Vaccine Product
 Table 154. TapImmune Recent Developments/Updates
 Table 155. Targovax Company Information
 Table 156. Targovax Description and Business Overview
 Table 157. Targovax Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 158. Targovax Peptide Vaccine Product
 Table 159. Targovax Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Peptide Vaccine Distributors List
 Table 163. Peptide Vaccine Customers List
 Table 164. Peptide Vaccine Market Trends
 Table 165. Peptide Vaccine Market Drivers
 Table 166. Peptide Vaccine Market Challenges
 Table 167. Peptide Vaccine Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Peptide Vaccine
 Figure 2. Global Peptide Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peptide Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Solution Phase Synthesis (SPS) Product Picture
 Figure 5. Solid Phase Peptide Synthesis (SPPS) Product Picture
 Figure 6. Global Peptide Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Peptide Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Prostate Cancer
 Figure 9. Breast Cancer
 Figure 10. Gastric Cancer
 Figure 11. Lung Cancer
 Figure 12. Pancreatic Cancer
 Figure 13. Others
 Figure 14. Global Peptide Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Peptide Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Peptide Vaccine Sales (2020-2031) & (K Dose)
 Figure 17. Global Peptide Vaccine Average Price (US$/Dose) & (2020-2031)
 Figure 18. Peptide Vaccine Report Years Considered
 Figure 19. Peptide Vaccine Sales Share by Manufacturers in 2024
 Figure 20. Global Peptide Vaccine Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Peptide Vaccine Players: Market Share by Revenue in Peptide Vaccine in 2024
 Figure 22. Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Peptide Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Peptide Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. North America Peptide Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. United States Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Peptide Vaccine Sales Market Share by Country (2020-2031)
 Figure 29. Europe Peptide Vaccine Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Peptide Vaccine Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Peptide Vaccine Revenue Market Share by Region (2020-2031)
 Figure 37. China Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Peptide Vaccine Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Peptide Vaccine Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Peptide Vaccine Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Peptide Vaccine Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Peptide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Peptide Vaccine by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Peptide Vaccine by Type (2020-2031)
 Figure 58. Global Peptide Vaccine Price (US$/Dose) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Peptide Vaccine by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Peptide Vaccine by Application (2020-2031)
 Figure 61. Global Peptide Vaccine Price (US$/Dose) by Application (2020-2031)
 Figure 62. Peptide Vaccine Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Synthetic Peptide Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Peptide Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Based Vaccines for Cancer Market Research Report 2025
Peptide Based Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adjuvant Peptide Market Research Report 2024
Peptide Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Vaccine for Tumor Market Research Report 2024
Global Protein and Peptide Therapeutics Market Research Report 2025
Injectable Peptides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polypeptide Vaccine Market Research Report 2024
Peptide based Injectable Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Peptide Synthesis Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeting Peptides Market Research Report 2024
Global Peptide Based Cancer Therapeutics Market Research Report 2024
Peptide based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide based Generics Market Research Report 2024
Global Injection Peptide Drug Market Research Report 2025
Global Peptide Carrier Protein Conjugates Market Research Report 2024
Global Biological Vaccines Adjuvants Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions